Abstract E-selectin and P-selectin are thought to be important in the in®ltration of T lymphocytes in in¯ammation, but their role in cytokine-induced cutaneous in¯ammatory reactions has not been examined. A technique for quantifying labeled T lymphocyte migration to cytokine-induced dermal in¯ammation in mice was developed. After i.v. injection, 51 Cr-labeled T lymphocytes migrated to lesions induced by IFN-g and tumor necrosis factor (TNF)-a, and in even greater numbers to the combination of IFN-g + TNF-a, and to sites injected with concanavalin A (Con A). In E-selectin mAbtreated and in E-selectin-de®cient mice, IFN-g-, IFN-g + TNF-a-and Con A-induced T cell accumulation was inhibited by 45±65%, but TNF-a-induced in®ltration was unaffected. In P-selectin mAb-treated and P-selectin-de®cient mice, T cell accumulation remained unchanged in most of the lesions. Combined, E-selectin and P-selectin mAb treatment inhibited T cell accumulation in all four types of reactions, and signi®cantly more than E-selectin blockade alone in migration to Con A. Results in E-selectin-and P-selectin-de®cient mice con®rmed these observations, and demonstrated strain-dependent differences in the contributions of the two selectins. In conclusion, T cells migrating to dermal in¯ammatory reactions utilize both E-selectin and P-selectin, but alternate adhesion pathways also contribute, since blocking both endothelial selectins does not abolish T cell migration. P-selectin plays a less important role than E-selectin, since blocking Eselectin, but not P-selectin, alone decreased T cell accumulation. The relative contribution of the selectins varies depending on the initiating in¯ammatory stimulus and the genetic background.
Introduction
In¯ammation is characterized by leukocyte migration into the in¯amed tissue. T lymphocytes are found in many skin in¯ammatory reactions in man and are important contributors to these reactions (1) . The mechanism of T lymphocyte migration from blood into in¯amed tissues is not well de®ned. Leukocyte migration involves several steps. The initial interaction of leukocytes with vascular endothelium is transient and low in af®nity, resulting in the rolling of the leukocyte on the vascular endothelial cells. This is followed by leukocyte activation, ®rm adhesion and transmigration (2, 3) . Generally, selectins mediate the initial interaction of leukocytes with endothelium, whereas integrins mediate ®rm adhesion and transmigration.
Selectins are a family of calcium-dependent adhesion molecules with an extracellular lectin-like carbohydratebinding domain. Three members, L-selectin, E-selectin and P-selectin, have been identi®ed. L-selectin is expressed on leukocytes, E-selectin is expressed on activated endothelium, and P-selectin is expressed both on activated endothelium and activated platelets. P-selectin is stored in Weibel-Palade bodies in endothelial cells and a-granules in platelets (4, 5) , and is rapidly expressed on the cell surface upon stimulation with thrombin, histamine, tumor necrosis factor (TNF)-a, IFN-g and IL-1 (6±8). E-selectin expression requires de novo synthesis, and is therefore delayed (9) . TNF-a and IL-1 induce E-selectin synthesis and surface expression on endothelial cells, and IFN-g has been shown to induce E-selectin expression on human dermal microvascular cells in vitro (9±11).
E-selectin has been proposed to be critical for T lymphocyte migration to skin in¯ammatory reactions (12) . A subset of T cells express a ligand for E-selectin, the cutaneous lymphocyte antigen (CLA) (12, 13) . These T cells comprise <5% of T lymphocytes in extracutaneous in¯am-matory sites, but represent 80±90% of the T cells found in skin lesions of patients with skin in¯ammatory conditions (14) . Direct evidence for the role of E-selectin in in vivo T lymphocyte migration comes from blocking antibody studies. Anti-E-selectin mAb partially inhibited blood lymphocyte recruitment to delayed-type hypersensitivity (DTH) reactions in pigs (15) and tuberculin DTH reactions in some Macaque monkeys (16) . Anti-E-selectin mAb also partially inhibited the migration to contact hypersensitivity reactions in mice of in vivo stimulated mouse CD4 + T cells of the T h 1 phenotype (17) . Although antibody studies have shown a role for E-selectin in T lymphocyte migration, in Eselectin-de®cient mice contact sensitivity reactions were not histologically different from those in wild-type mice (18, 19) and leukocyte rolling after TNF-a stimulation was not altered (18, 19) .
The role of P-selectin in mediating in vivo T cell migration is not clear. T cells roll on immobilized P-selectin in¯ow chambers (20, 21) . In P-selectin-de®cient animals the number of CD4 + T cells in contact hypersensitivity reactions was found to be decreased (22) and anti-Pselectin mAb partially inhibited the migration of cultured CD4 + T h 1 cells to contact hypersensitivity reactions in mice (17) , demonstrating P-selectin involvement in in vivo T cell migration.
Systematic evaluation of the role of E-selectin and P-selectin in in vivo T lymphocyte migration to various intradermally (i.d.) injected in¯ammatory agents has not been reported. Our studies were designed to examine the contribution of Eselectin and P-selectin to T lymphocyte in®ltration in vivo in cutaneous in¯ammatory reactions, with the goal of determining the importance of each of these molecules. We used 51 Crlabeled spleen T lymphocytes to quantify T cell migration to i.d. injected IFN-g, a major cytokine responsible for T cell migration to DTH reactions (23), TNF-a and concanavalin A (Con A), a mitogen which induces DTH-like reactions in rats and pigs (24) .
Our results demonstrate that T lymphocytes use both Eselectin and P-selectin for in vivo migration into cutaneous in¯ammatory tissues in mice. In general, E-selectin contributes more than P-selectin to the migration of T lymphocytes, but the relative contributions vary depending on the in¯ammatory stimulus. However, the absence of both E-selectin and Pselectin does not abolish T lymphocyte migration to dermal in¯ammatory reactions, suggesting alternate adhesion pathways are also involved in the initial interaction with the vascular endothelium.
Methods

Animals and reagents
C57Bl/6J (B6) and C57Bl/6J-Selp tm1Bay (P ±/± ), P-selectin-de®-cient mice, were obtained from Jackson Laboratories (Bar Harbor, ME). 129Sv mice and 129Sv-Sele (E ±/± /129Sv) and C57Bl/6-Sele (E ±/± /B6), E-selectin-de®cient mice of C57Bl/6 and 129Sv backgrounds, were from Hoffman-La Roche (Nutley, NJ). All experiments involved 6-to 10-week-old male mice.
Mouse recombinant TNF-a was kindly provided by Genentech (South San Francisco, CA). Recombinant rat IFNg was a generous gift of Dr Peter Van der Meide (TNO Primate Center, Rijswijk, The Netherlands). Lipopolysaccharide contamination was <10 EU/mg in all the cytokines. Con A was obtained from Sigma (St Louis, MO).
mAb
The mAb 9A9E3.F10 (9A9) was a generous gift from HoffmanLa Roche. It is a rat IgG2b which recognizes mouse E-selectin. 9A9 inhibits mouse PMN adhesion to E-selectin transfected COS cells and HL-60 promyelocyte adhesion to stimulated mouse eEnd.2 endothelial cells (25) . RMP-1 is a mouse IgG2a mAb which reacts with mouse P-selectin on activated platelets. RMP-1 blocks P-selectin-dependent adhesion of HL-60 cells to recombinant mouse P-selectin and reacts with Pselectin on activated mouse platelets (26) . 5H1 (IgG1) is a rat anti-mouse P-selectin mAb. It recognizes P-selectin induced by TNF-a on murine eEnd.2 endothelial cells, and blocks Pselectin function in vitro and in vivo (18) . Control mAb included SFR3-DR5, a rat anti-HLA-DR5 antibody, as an isotypematched control for 9A9 and 5H1, and B9 (IgG1), a mouse anti-pertussis toxin antibody (27) , as a control for RMP-1. Rat IgG (Sigma) was used as an additional control for 9A9 and 5H1.
Lymphocyte isolation and labeling
Animals were killed by cervical dislocation. The spleens of the animals were removed and passed through a wire mesh to obtain a cell suspension. The red blood cells were lysed with 0.84% Tris±ammonium chloride. T cells from the spleen were isolated by passing the spleen cells over a nylon wool column for 1 h at 37°C. The isolated spleen T lymphocytes were >95% CD3 + , contaminating cells being B cells and <1% other cells, and were > 98% viable by Trypan blue dye exclusion.
For labeling T lymphocytes were suspended at 5 Q 10 7 cells/ml in HBSS, containing 15mM HEPES and 10% FBS, and incubated with 50 mCi Na 2 51 CrO 4 /ml at 37°C for 45 min. The cells were then washed twice in RPMI 1640 medium and resuspended in RPMI 1640 containing 0.1% human serum albumin for i.v. injection.
Measurement of T lymphocyte migration in vivo
B6, 129Sv wild-type mice, or E-selectin or P-selectin-de®cient mice were injected i.v. with 10 7 radiolabeled T cells carrying 10 5 c.p.m. in a volume of 200 ml. Immediately afterwards the mice were anesthetized with methoxy¯uorane, the backs of the animals were shaved, and 10 ml of lymphocyte recruiting agents and control diluent were injected i.d. in six sites. Two sites were injected with the diluent and four sites with each of the test samples. After 22 h, at a time previously found to be optimal for the measurement of T cell accumulation (23) , the animals were anesthetized with methoxy¯uorane, and 500 ml of heparinized blood was collected by heart puncture and the mice were killed. The inguinal and axillary lymph nodes, spleen, lung and liver were removed and weighed. Dorsal skin, including the area of the dermal in¯ammatory reactions was removed, washed and blood squeezed out of any super®cial veins. The injected areas were punched out with a 9-mm leather punch. This produced a circular piece of tissue with a standard surface area. The injected skin sites, the resected organs and the remaining mouse parts were counted in an 1480 WIZARD 3 g-spectrometer. The blood was centrifuged and the plasma and cell pellet counted separately. About 70±80% of the injected radioactivity was recovered. The 51 Cr content of all tissues was normalized for 10 5 c.p.m. recovered after 22 h. The number of labeled T cells in the tissues was determined as follows. The speci®c activity of the labeled cells, i.e. the number of i.v. injected T cells/ 51 Cr c.p.m., was calculated and used to convert the 51 Cr c.p.m. of the tissues to the numbers of labeled T cells/site.
mAb treatment
The effect of the mAb on T lymphocyte migration in vivo was assessed by giving animals an i.v. injection of 200 mg 9A9, 100 mg RMP-1, 200 mg 5H1 or 100±200 mg of the control antibodies in 100 ml of sterile saline immediately before an i.v. injection of the labeled lymphocytes. These doses of the mAb produced blood levels >20 mg/ml after 22 h, as assessed by an ELISA of the plasma samples. None of the mAb treatments produced leukopenia or clearance of the 51 Cr lymphocytes from the circulation. The T cell migration in animals receiving the control antibodies was not different from mice receiving no antibody, so the results of these two groups were pooled.
Measurement of plasma mAb concentration
The plasma concentration of 9A9 was measured by ELISA using the following protocol. MaxiSorb Immunoplates (Nunc, Roskilde, Denmark) were coated with a 1 mg/ml goat anti-rat IgG antibody, adsorbed to remove cross-reactivity to mouse IgG (Caltag, Burlingame, CA), at 4°C overnight. The wells were blocked with 10% normal goat serum and incubated for 1 h at 37°C with dilutions of the plasma samples. After washing, alkaline phosphatase-conjugated goat anti-rat IgG (Caltag) was added and incubated for 1 h. After washing, the reaction was developed with p-nitrophenylphosphate (Sigma) and the absorbency read at 405 nm on a Titertek Multiscan microplate reader.
The plasma concentration of the mouse mAb RMP-1, was measured by ELISA. Brie¯y, rat platelets (5 Q 10 6 in 100 ml) were added to wells in 96-well tissue culture plates (Nunc, Gibco/BRL, Mississagua, Ontario, Canada) and spun down at 4°C to form a monolayer. The platelets were activated by adding 1 U/ml bovine a-thrombin for 5 min at 37°C and ®xed with 1% paraformaldehyde in PBS for 45 min. Fixation was stopped with 0.05 M Tris/0.1 M glycine for 15 min. The wells were blocked with 10% NGS followed by the incubation with the plasma samples. Horseradish peroxidase-conjugated goat anti-mouse IgG was added to the samples and incubated for 1 h at 37°C. After washing the reaction was developed with the o-phenylenediamine and the absorbance read at 492 nm.
Statistical analysis
Results are expressed as means T SEM of multiple animals. Student's unpaired t-test was used to compare the difference between means.
Results
Lymphocyte migration to dermal in¯ammatory reactions
The migration of i.v. injected, 51 Cr-labeled T lymphocytes to a variety of dermal in¯ammatory reactions was examined. At 22 h after i.d. injection of the in¯ammatory stimuli, large numbers of T cells had migrated into the lesions. Figure 1 (A) shows that the labeled T lymphocytes accumulated in markedly higher numbers in skin sites injected with the in¯amma-tory agents than in the sites injected with the diluent. This accumulation was 4-to 5-fold greater in sites injected with IFNg or TNF-a than in control diluent sites, and 10-fold greater in the site injected with the combination of IFN-g + TNF-a than in control diluent site. Among the tested agents, Con A was by far the most potent inducer of T cell migration, producing 40-fold greater accumulation of the labeled T cells than the diluent control. Figure 1 (B) shows that the i.v. injected labeled T cells migrated to lymphoid organs such as the spleen and the lymph nodes. The accumulation of labeled T cells in the liver, which removes non-viable cells from the circulation was low. Taken together, these ®ndings suggest that the labeled T cells migrate in a physiological manner and accumulate in cutaneous in¯ammatory sites. 
The effect of mAb to E-selectin on T lymphocyte migration
In order to determine the role of E-selectin in in vivo T lymphocyte migration, B6 mice were injected i.v. with 51 Cr T lymphocytes and treated with a control mAb or a blocking anti-E-selectin mAb. The administration of the control antibodies had no effect on T cell migration. Figure 2(A) shows that the i.v. injection of anti-E-selectin mAb signi®cantly inhibited T cell accumulation in response to IFN-g 60% (P < 0.05), to the combination of IFN-g + TNF-a by 45% (P < 0.05) and to Con A by 65% (P < 0.01). E-selectin blockade had no effect on the migration of T lymphocytes to TNF-a alone. Figure 2 (B) shows that anti-E-selectin treatment had no effect on the accumulation of radiolabeled T cells in the spleen and lymph nodes, as compared to control antibody-treated animals. The anti-E-selectin mAb did not cause leukopenia (data not shown), and the numbers of T cells in the blood and liver of animals treated with anti-E-selectin were not signi®-cantly different from those treated with control antibodies or those not receiving antibody (Fig. 2B) , suggesting that the observed effect of E-selectin mAb on T cell accumulation in in¯ammation was not due to a non-speci®c effect on T cell migration.
T cell migration in E-selectin-de®cient mice
The role of E-selectin in T cell migration to skin in¯ammation was also investigated using E-selectin-de®cient mice. Figure 2 (A) shows that in E-selectin-de®cient B6 mice the migration of labeled T cells to IFN-g induced accumulation was inhibited by 65% (P < 0.001), to IFN-g + TNF-a by 50% (P < 0.05) and to Con A by 60% (P < 0.01). Analogous to the animals treated with the anti-E-selectin mAb, T cell migration to the TNF-a induced lesion in E-selectin-de®cient mice was not affected.
The results obtained from E-selectin-de®cient 129Sv mice were somewhat different than the E ±/± B6 mice. Figure 3 shows that although B6 and 129Sv wild-type control mice did not differ in the magnitude of the T cell responses to the in¯ammatory agents tested, E-selectin-de®cient B6 and 129Sv mice did. In E ±/± /129Sv mice, the migration of labeled T cells was inhibited to the Con A in¯ammatory site by 50% (P < 0.05), but not to the other in¯ammatory agents tested.
Effect of anti-P-selectin treatment on T lymphocyte migration
In order to determine the role of P-selectin in in vivo T lymphocyte migration to in¯ammatory reactions in the skin, B6 mice were injected i.v. with 51 Cr-labeled T lymphocytes and treated with control mAb or the anti-P-selectin mAb. Figure 4 shows that the infusion of the anti-P-selectin mAb, either RMP-1 or 5H1, did not signi®cantly affect T cell migration to any of the in¯ammatory agents tested. Anti-P-selectin mAb treatment also did not affect the accumulation of T cells in the spleen or the lymph nodes (data not shown), indicating that P-selectin is probably not involved in T cell migration to these sites.
T cell migration in P-selectin-de®cient animals
In order to examine the role of P-selectin further, the migration of T lymphocytes to cutaneous in¯ammatory lesions was studied in P-selectin-de®cient mice. Figure 4 indicates that the accumulation of labeled T lymphocytes in skin lesions injected with IFN-g, TNF-a, the combination of IFN-g + TNF-a and Con A in P ±/± /B6 mice was not different from that of wild-type B6 mice. The only T cell response that was slightly inhibited was the migration to the combination of IFN-g + TNF-a, which was inhibited by~25%. This result agrees with those from the experiments with blocking mAb (Fig. 4) , where anti-P-selectin did not affect T lymphocyte migration to skin lesions, suggesting that P-selectin function is not critical for T Fig. 3 . T cell migration to cutaneous in¯ammatory reactions in Eselectin-de®cient B6 and 129Sv mice. Wild-type B6 and 129Sv mice and E-selectin-de®cient B6 and 129Sv mice were given i.v. 51 Crlabeled T lymphocytes from wild-type B6 and 129Sv spleens. The animals were injected i.d. with the indicated stimuli, as described in Fig. 1 . After 22 h, they were sacri®ced, and the radioactivity in the i.d. sites was measured and expressed as in Fig. 1 . Each bar represents the mean T SEM with six or seven animals per group. + P < 0.05; *P < 0.001. Fig. 2 . Effect of anti-E-selectin and E-selectin de®ciency on T lymphocyte migration to cutaneous in¯ammatory reactions and organs. Wild-type B6 mice were injected i.v. with control mAb or anti-E-selectin mAb followed by the i.v injection of 51 Cr-labeled T lymphocytes. E-selectin-de®cient B6 mice were given i.v. 51 Crlabeled T cells derived from wild-type B6 spleens. The animals were then given i.d. injections with the indicated stimuli at the concentrations described in Fig. 1 . After 22 h, animals were sacri®ced, and the radioactivity in the i.d. sites and organs was measured. The 51 Cr accumulation is expressed as in Fig. 1 . Each bar represents the mean T SEM with six or seven animals per group. + P < 0.05; Q P < 0.01. lymphocyte accumulation in these cutaneous in¯ammatory sites.
Effect of treatment with anti-E-selectin and anti-P-selectin on T lymphocyte migration
Mice were also treated with the combination of the anti-Eselectin and anti-P-selectin mAb. Figure 5 shows that the combined mAb treatment inhibited T cell recruitment to all four types of in¯ammatory reactions, but to a varying extent. The inhibitory effect was greatest (80%) for Con A (P < 0.001), 55% for IFN-g (P < 0.01), 50% for the IFN-g + TNF-a combination (P < 0.001) and 40% for TNF-a (P < 0.01). The migration of T lymphocytes to Con A and to TNF-a was inhibited signi®cantly more in animals treated with both anti-E-selectin plus anti-Pselectin than in those treated with anti-E-selectin mAb alone (Fig. 5) . The combined anti-E-selectin and anti-P-selectin treatment did not alter the migration of T lymphocytes to the spleen or lymph nodes (data not shown).
Effect of anti-E-selectin and anti-P-selectin in P-selectin-and E-selectin-de®cient mice
The roles of E-selectin and P-selectin in T lymphocyte migration to dermal in¯ammatory reactions was further examined by treating E-selectin-de®cient mice (E ±/± /129Sv) with the anti-P-selectin mAb, RMP-1 and P-selectin-de®cient mice with the anti-E-selectin mAb, 9A9 (Fig. 6) .
As shown previously, cytokine-induced T cell accumulation in the E ±/± /129 mice was not affected and Con A-induced accumulation was reduced by~40%. Anti P-selectin treatment, however, in these animals signi®cantly inhibited T cell recruitment to all four in¯ammatory lesions. The migration of T cells to each of the in¯ammatory reactions was inhibited more in E ±/± /129Sv mice treated with anti-P-selectin than in untreated E ±/± /129Sv. Similar to the effect of anti-E-selectin plus anti-Pselectin treatment in normal mice, the inhibitory effect was greatest with Con A (75%) (P < 0.01). Figure 6 (B) shows that the i.v. injection of anti-E-selectin mAb in P-selectin-de®cient mice also signi®cantly inhibited T cell accumulation in all four types of lesions. Similar to animals given the combination of anti-E-selectin and anti-P-selectin treatment and in E-selectin-de®cient mice treated with anti-Pselectin mAb, the inhibitory effect was greatest (87%) for Con A (P < 0.001), and somewhat less for IFN-g (60%) (P < 0.01) and for TNF-a (40%) alone or the combination of IFN-g + TNF-a (P < 0.05).
Discussion
These studies demonstrate that, by using the techniques described in this report, radiolabeled spleen T lymphocytes can be used to investigate the in vivo mechanisms of T cell migration into dermal in¯ammation induced by de®ned cytokines and other stimuli in mice. Mouse T lymphocyte migration to the i.d. injected cytokines, IFN-g and TNF-a could be readily determined. Studies of T lymphocyte recruitment to in¯ammation in mice have been restricted primarily to studies of contact hypersensitivity and have been problematic because of the dif®culties in quantifying T cells in the in¯amed tissue, since they often represent only a small fraction of the cellular in®ltrate. Consequently, T lymphocyte accumulation has usually been measured indirectly by quantifying ear thickness in contact hypersensitivity reactions (18, 28) . However, increases in ear thickness, which measure plasma leakage and ®brin deposition, do not always correlate with the number of in®ltrating T cells, especially when de®ned cytokines are used to induce an in¯ammatory reaction (22) . The use of radiolabeled T lymphocytes provides a substantial advantage by allowing T cell migration to various in¯ammatory stimuli in multiple organs to be quanti®ed.
We chose mice to study the mechanisms of lymphocyte migration to take advantage of E-selectin and P-selectinde®cient mice. In vivo studies of leukocyte migration have frequently been carried out using mAb to block the function of adhesion receptors. A common criticism of this method is that mAb may be exerting non-speci®c effects, either by activating cells through the receptor they bind to or by mediating Fc receptor interactions. Adhesion molecule-de®cient mice offer an alternative to mAb, but may also be problematic since these mice may have developmental alterations in the Fig. 5 . Effect of combined anti-E-selectin and anti-P-selectin treatment on T lymphocyte migration to cutaneous in¯ammatory reactions. Wild-type B6 mice were injected i.v. with anti-E-selectin (9A9) plus anti-P-selectin (RMP-1) or control mAb and immediately afterwards 51 Cr-labeled T lymphocytes were injected i.v. The animals were then given i.d. injections with the indicated stimuli at the concentrations described in Fig. 1 . After 22 h, animals were sacri®ced, and the radioactivity in the i.d. sites and organs was measured. The 51 Cr accumulation is expressed as in Fig. 1 . Each bar represents the mean T SEM with six or seven animals per group. + P < 0.05; Q P < 0.01; *P < 0.001. Fig. 4 . Effect of anti-P-selectin and P-selectin de®ciency on T lymphocyte migration to cutaneous in¯ammatory reactions. Wildtype B6 mice were injected i.v. with control mAb, anti-P-selectin mAb, 5H1 or RMP-1, followed by the i.v injection of 51 Cr-labeled T lymphocytes. P-selectin-de®cient B6 mice were given i.v. 51 Crlabeled T cells derived from wild-type B6 spleens. The animals were then given i.d. injections with the indicated stimuli at the concentrations described in Fig. 1 . After 22 h, the mice were sacri®ced, and the radioactivity in the i.d. sites was measured and is expressed as in Fig. 1 . Each bar represents the mean T SEM with seven animals per group. Q P < 0.01. expression of adhesion molecules as compared to the wildtype. To avoid these potential problems, we investigated T cell migration in both antibody-treated and selectin-de®cient mice, and compared the results.
Our results suggest several novel ®ndings with regard to the utilization of E-selectin and P-selectin by T lymphocytes for migration to various in¯ammatory stimuli in the skin. Anti-Eselectin treatment signi®cantly inhibited T cell migration to all of the stimuli except TNF-a (Fig. 2) . In E-selectin-de®cient C57BL/6 mice, T lymphocyte migration was also impaired to all stimuli except TNF-a (Fig. 2) . The inhibition of T cell migration in the absence of functional E-selectin suggests that T cells require E-selectin for migration to a variety of in¯ammatory reactions in the skin. These observations suggest that mouse T cells have functional ligands for E-selectin. CLA, which was described on skin homing human T lymphocytes, is a possible ligand, but a mouse homologue has not yet been identi®ed. Lselectin is another possible ligand. L-selectin, which is expressed on the majority of blood leukocytes, was shown to mediate human neutrophil adhesion to E-selectin (29) . Yet another E-selectin ligand has been identi®ed on bovine gd T cells (30) . The inhibition of T cell migration observed in our model, however, is unlikely to be due to the inhibition of gd T cells, since these comprise <1% of the T cells in mouse spleen (31) .
The results indicate that E-selectin is important for mediating T lymphocyte migration in this model and its function could not be substituted by other adhesion molecules. Nevertheless, in both anti-E-selectin mAb-treated and E-selectin-de®cient mice, T cell migration to skin lesions was only partially decreased, indicating that either only a subpopulation of T lymphocytes utilize E-selectin for entry into in¯amed skin or T cells can use E-selectin-independent mechanisms for migration to skin. In contrast to E-selectin, P-selectin by itself appeared to play a relatively minor role in T lymphocyte migration to skin in¯ammation in this model. Two different function-blocking mAb to mouse P-selectin had no effect on in vivo T cell migration to the four i.d. injected in¯ammatory agents (Fig. 3) . This lack of inhibition was not due to low antibody levels in the mAb-treated animals, since higher doses of anti-P-selectin mAb also did not affect T cell migration and blocking levels (>20 mg/ml) of anti-P-selectin mAb remained in the serum after 22 h (data not shown). The lack of effect of anti-P-selectin treatment was not the result of failure of the mAb to block the receptor. Both 5H1 and RMP-1 have been shown in vitro to block P-selectin-dependent adhesion of HL-60 cells (18, 26) , and in vivo 5H1 blocked neutrophil migration to peritonitis in E-selectin-de®cient mice (18) , con®rming that these antibodies block P-selectin-mediated adhesion and migration. In our studies, anti-P-selectin mAb further suppressed T lymphocyte migration in vivo when used in conjunction with anti-E-selectin mAb, or in E-selectinde®cient mice (Figs 5 and 6) , con®rming that the anti-Pselectin mAb are indeed function blocking. Furthermore, T cell migration in P-selectin-de®cient mice was also unaffected, except to one lesion. Thus, in conclusion, the mAb to Pselectin are effective blockers, but P-selectin, although involved, is not essential for T cell migration in this model.
The minor role for P-selectin in T cell migration is not due to absence of P-selectin ligands on T cells. The P-selectin glycoprotein ligand (PSGL-1), a high af®nity P-selectin ligand on myeloid cells (32, 33) , has also been shown to be expressed on T cells, and can mediate T cell adhesion and rolling in vitro (20, 21, 34) . Furthermore, blocking P-selectin in addition to E-selectin further suppressed T cell recruitment in the Con A lesion and was required to observe inhibition of T cell migration to TNF-a (Fig. 5) , indicating that T cells have ligands for P-selectin, and that both E-selectin and P-selectin contribute to T lymphocyte recruitment to skin in¯ammation in this model.
Blocking both E-selectin and P-selectin did not completely inhibit T lymphocyte migration to in¯amed skin, indicating that at least one other receptor must be capable of mediating T cell tethering and rolling. Even in the Con A lesion, where blocking both endothelial selectins resulted in the greatest inhibition of T lymphocyte migration, T cell accumulation was suppressed by only 80%. This residual T cell migration may be mediated by L-selectin, since it can mediate T cell tethering in vivo (35) , and L-selectin has been shown to be involved in the migration of mononuclear cells to peritonitis (36) . Alternatively, the T cell tethering may be mediated by VLA-4. VLA-4, an integrin expressed on the majority of lymphocytes, was reported to support T lymphocyte tethering and rolling in vitro (37±39) and rolling in vivo (35, 40) via the counter-receptor, vascular cell adhesion molecule (VCAM)-1. Recent studies using a rat Fig. 6 . T cell migration to cutaneous in¯ammatory reactions in Eselectin-de®cient mice treated with anti-P-selectin mAb and Pselectin-de®cient mice treated with anti-E-selectin mAb. E-selectin (129Sv)-and P-selectin (B6)-de®cient mice were injected i.v. with anti-P-selectin mAb (RMP-1) and anti-E-selectin (9A9) mAb respectively, and wild-type mice were injected i.v. with control mAb. Immediately afterwards animals were given i.v. 51 Cr-labeled T lymphocytes followed by i.d. injection of the indicated stimuli at the concentrations described in Fig. 1 . After 22 h, animals were sacri®ced, and the radioactivity in the i.d. sites and organs was measured. The 51 Cr accumulation is expressed as in Fig. 1 . Each bar represents the mean T SEM with six to nine animals per group. + P < 0.05; Q P < 0.01; *P < 0.001. T cell accumulation in single knockout animals is presented for comparison.
model of dermal in¯ammation and exclusively a mAb blocking approach, suggest that VLA-4 may be mediating the Eselectin-and P-selectin-independent migration (41) . Another possibility is a yet unidenti®ed receptor capable of initiating tethering and rolling of T cells, independent of E-selectin and P-selectin.
Our results regarding E-selectin utilization by T lymphocytes for migration to skin in¯ammation agree with those of Binns et al. (15) , who found that anti-E-selectin mAb partially inhibited blood lymphocyte recruitment to cutaneous DTH in sensitized pigs, and with those of Silber et al., who showed that anti-E-selectin treatment can partially inhibit the intensity of T cell in®ltrates in the skin in some Macaque monkeys (16) . Our results also agree with those of Austrup et al. (17) , who demonstrated partial inhibition of cultured T h 1 cell migration to contact sensitivity reactions with anti-E-selectin treatment.
In contrast to these results, contact sensitivity reactions in Eselectin-de®cient mice, as measured by ear thickness measurements and histological observations, were not different from wild-type (18, 19) . However, contact sensitivity reactions in mice are heavily in®ltrated by neutrophils, which may not depend on E-selectin for their migration (42) .
Our results regarding P-selectin utilization by T cells migrating to skin in¯ammation contrast with those of Austrup et al. (17) , who demonstrated partial inhibition of cultured T h 1 cell migration to a contact sensitivity reaction with anti-Pselectin treatment. However, these T cells were cultured in vitro and stimulated to develop a T h 1 or T h 2 cytokine pro®le, before being injected in vivo. Therefore their requirement for Pselectin may be different from that of resting T cells.
Subramaniam et al. demonstrated decreased CD4 + T cell numbers in contact hypersensitivity reactions in P-selectinde®cient animals (22) . This observation is in contrast with our results, which show that P-selectin is not essential for T cell migration to skin lesions within the ®rst 24 h. The observed difference in P-selectin utilization by T cells may be related to the in¯ammatory agent used to elicit skin in¯ammation: the contact sensitizing agent oxazolone versus i.d. injected cytokines and Con A. Their studies demonstrate that Pselectin-de®cient mice had decreased neutrophil accumulation in contact hypersensitivity reactions at 24 h as compared to the wild-type, whereas several other studies report no decrease in neutrophil accumulation in contact hypersensitivity reactions, in either anti-P-selectin-treated or in P-selectinde®cient mice at 24 h (18, 19) . Our results agree with those of Tang et al., showing that in P-selectin-de®cient mice, mononuclear cell accumulation in the in¯amed cerebrospinal¯uid is not inhibited at 24 h (43), and to those of Tang et al., showing that P-selectin-de®cient mice reject allogeneic skin grafts normally (44) .
Another interesting ®nding was that, in contrast to the other stimuli used, T cell migration to TNF-a was not inhibited in anti-E-selectin mAb-treated or E-selectin-de®cient mice. TNF-a has been shown to be a potent inducer of E-selectin expression on dermal vascular endothelial cells both in vitro and in vivo (9±11,45±48). TNF-a also induces considerable T lymphocyte recruitment when injected i.d. in mice, as shown here, as well as in other species (46,48±50) . Furthermore, Binns et al. have shown a correlation between E-selectin expression and T cell migration to TNF-a lesions (46) . Together, these ®ndings strongly suggest an essential role for E-selectin in T cell migration to TNF-a. However, our results indicate that while E-selectin is involved, it is not essential for T cell migration to TNF-a-induced dermal in¯ammation in the mouse; P-selectin appears able to substitute for E-selectin function, as functional absence (either by mAb treatment or in selectin-de®cient mice) of either receptor alone did not affect T cell migration to TNF-a (Figs 2±4), whereas eliminating both Eselectin and P-selectin function resulted in signi®cant inhibition (Figs 5 and 6 ). The explanation for these observations may lie in the ability of another receptor to substitute for Eselectin or P-selectin function in mediating T cell migration to TNF-a. One possible candidate is VCAM-1, an activation inducible endothelial adhesion molecule. TNF-a induces VCAM-1 expression on endothelial cells (51, 52) , and VCAM-1, as mentioned earlier, supports tethering and rolling of T cells in vitro via VLA-4 (37±39). Some in vivo studies, however, suggest that this interaction supports rolling, but not tethering, of leukocytes (35, 40) . It remains to be determined which adhesion molecules are involved in T cell migration to TNF-a.
The ®nding that anti-E-selectin mAb treatment inhibited T cell migration to IFN-g suggests that E-selectin is present on dermal vascular endothelium in mice. Literature disagrees on this issue because IFN-g has been shown to induce E-selectin expression on human dermal microvascular endothelial cells (10), but not on cultured human umbilical vein endothelium or in vivo in mouse skin (11) . Our results suggest that IFN-g induces E-selectin expression on vascular endothelial cells when injected i.d. in mice.
The observation that combined E-selectin and P-selectin blockade did not inhibit T cell migration to IFN-g more than Eselectin blockade alone (Fig. 5) suggests that P-selectin may have minimal involvement in T cell migration to IFN-g. This is in keeping with lack of effect on T cell migration to IFN-g of Pselectin blockade or genetic deletion (Fig. 4) . P-selectin is stored within the Weibel-Pallade bodies of endothelial cells and is rapidly (<30 min) up-regulated after cytokine activation of the endothelium (4±8). E-selectin expression is thought to require de novo synthesis by the endothelium and takes 2±3 h to be up-regulated (9±11). This suggests that there may be a greater reliance for leukocyte migration on P-selectin early during an in¯ammatory reaction. Unfortunately, it was not possible to test differences in the kinetics of T cell migration in the absence of E-selectin or Pselectin in the mouse model used here, because the numbers of T cells accumulating are relatively small in response to the in¯ammatory lesions studied; so that measurements over short time periods to determine the kinetics of migration are not possible. However, lymphocyte migration to the dermal in¯ammatory sites induced with cytokines, based on previous studies, takes several hours, so it is unlikely that signi®cant T cell accumulation occurs prior to both P-selectin and Eselectin being up-regulated on the endothelium (23) .
This study also sheds some light on the mechanisms of T cell migration to lymph nodes and spleen. The fact that blocking either E-selectin or P-selectin or both had no effect on T cell migration to lymph nodes and spleen suggests that neither of these molecules are required for T cell homing to these sites. Both E-selectin and P-selectin are expressed in human tonsil (53) , but their functional signi®cance in mediating T cell migration to lymphoid tissues has not yet been assessed. L-selectin, on the other hand, appears to be essential for lymphocyte migration to peripheral lymph nodes (54, 55) . This demonstrates that neither E-selectin nor P-selectin are involved in T lymphocyte migration to peripheral lymph nodes and spleen.
Our results indicate that 129Sv E-selectin-de®cient mice are different from B6 E-selectin-de®cient mice in the utilization of E-selectin for T cell migration. 129Sv mice and B6 mice have similar accumulation of labeled T lymphocytes in skin lesions, but T cell migration is partially decreased to lesions induced by IFN-g, IFN-g + TNF-a and Con A in E-selectin-de®cient B6 mice, but only to Con A in E-selectin-de®cient 129Sv mice (Fig. 3) . This lack of effect of E-selectin deletion in 129Sv mice was not due to the presence of E-selectin, because T cell migration to Con A in these mice was decreased. In addition, P-selectin mAb treatment in these mice inhibited T cell migration to all the lesions tested to the same extent as in E ±/ ± B6 mice (Fig. 6 ). Two reasons may account for the difference in T cell migration in E-selectin-de®cient mice of 129Sv and B6 backgrounds. First, there could be a strain difference such that 129Sv mice do not utilize E-selectin for T cell migration as much as do B6 mice. Ramos et al. (56) have reported differences in the effect of E-selectin blockade between BALB/c and C57BL/6 mice. Second, knocking out a gene may yield different compensatory mechanisms for the use of adhesion molecules on various backgrounds.
Our results suggest several important conclusions.
(i) They demonstrate that both E-selectin and P-selectin mediate part of the T lymphocyte migration to various in¯ammatory stimuli, since the absence of both selectins suppressed T cell migration to some of the stimuli further than the blockade of either of the selectins alone. (ii) There is an alternate adhesion pathway capable of initiating T cell migration to skin in¯am-mation in the mouse, since the absence of both endothelial selectins did not completely inhibit T cell migration to any of the agents tested. (iii) P-selectin function in T cell migration can be substituted by E-selectin or by another adhesion molecule, since the absence of P-selectin alone did not affect T cell migration. (iv) E-selectin function in T cell migration cannot be replaced by P-selectin or any other adhesion molecule, since a lack of E-selectin alone partially inhibited T cell migration to most stimuli tested.
In conclusion, these results show the complexity of in vivo T lymphocyte migration to in¯ammation and demonstrate the importance of studying adhesion molecules in the context of leukocyte migration to numerous stimuli. 
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